Picture of Bionovate Technologies logo

BIIO Bionovate Technologies Income Statement

0.000.00%
us flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro CapSucker Stock

Annual income statement for Bionovate Technologies, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2017
June 30th
2018
June 30th
2019
June 30th
2020
June 30th
2021
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue0.0050000
Cost of Revenue
Gross Profit0.0010
Selling / General / Administrative Expenses
Unusual Expense / Income
Total Operating Expenses0.3191.690.0570.0330.045
Operating Profit-0.314-1.69-0.057-0.033-0.045
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-0.341-1.74-0.209-0.122-0.107
Net Income After Taxes-0.341-1.74-0.209-0.122-0.107
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-0.323-1.74-0.209-0.122-0.107
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-0.323-1.74-0.209-0.122-0.107
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-38.3-2.7-1.34-0.005-0.002

Or unlock with your email

Or unlock with your email